Trial intelligence / Profile preview

Sugammadex versus neostigmine for postoperative shivering after abdominal laparoscopic surgery

PACTR202601785744919Phase 2Completed

Sponsor
Beni Suef University
Start
Mar 2024
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 2 trial of Sugammadex and neostigmine, sponsored by Beni Suef University. Started Mar 2024; status: completed.

02

Drugs

Sugammadexneostigmine

Beyond the preview

Go deeper on PACTR202601785744919.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202601785744919.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call